Lysine dihydrochloride, D- | CAS#10303-72-7

MedKoo Cat#: 530751 | Name: Lysine dihydrochloride, D-

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lysine dihydrochloride, D- is a bioactive chemical.

Chemical Structure

Lysine dihydrochloride, D-

CAS#10303-72-7

Theoretical Analysis

MedKoo Cat#: 530751

Name: Lysine dihydrochloride, D-

CAS#: 10303-72-7

Chemical Formula: C6H16Cl2N2O2

Exact Mass: 218.0589

Molecular Weight: 219.11

Elemental Analysis: C, 32.89; H, 7.36; Cl, 32.36; N, 12.79; O, 14.60

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Lysine dihydrochloride, D-

IUPAC/Chemical Name

D-Lysine, dihydrochloride

InChi Key

JBBURJFZIMRPCZ-ZJIMSODOSA-N

InChi Code

InChI=1S/C6H14N2O2.2ClH/c7-4-2-1-3-5(8)6(9)10;;/h5H,1-4,7-8H2,(H,9,10);2*1H/t5-;;/m1../s1

SMILES Code

N[C@H](CCCCN)C(O)=O.[H]Cl.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 219.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kolodziejczyk-Czepas J, Pasiński B, Ponczek MB, Moniuszko-Szajwaj B, Kowalczyk M, Pecio Ł, Nowak P, Stochmal A. Bufadienolides from Kalanchoe daigremontiana modulate the enzymatic activity of plasmin - In vitro and in silico analyses. Int J Biol Macromol. 2018 Dec;120(Pt B):1591-1600. doi: 10.1016/j.ijbiomac.2018.09.143. Epub 2018 Sep 24. PubMed PMID: 30261260. 2: Gründel A, Pfeiffer M, Jacobs E, Dumke R. Network of Surface-Displayed Glycolytic Enzymes in Mycoplasma pneumoniae and Their Interactions with Human Plasminogen. Infect Immun. 2015 Dec 14;84(3):666-76. doi: 10.1128/IAI.01071-15. PubMed PMID: 26667841; PubMed Central PMCID: PMC4771348. 3: Capulli M, Olstad OK, Onnerfjord P, Tillgren V, Muraca M, Gautvik KM, Heinegård D, Rucci N, Teti A. The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss. J Bone Miner Res. 2014 Aug;29(8):1833-46. doi: 10.1002/jbmr.2206. PubMed PMID: 24616121. 4: Mendes RS, Von Atzingen M, de Morais ZM, Gonçales AP, Serrano SM, Asega AF, Romero EC, Vasconcellos SA, Nascimento AL. The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection. Infect Immun. 2011 Nov;79(11):4657-67. doi: 10.1128/IAI.05583-11. Epub 2011 Aug 15. PubMed PMID: 21844229; PubMed Central PMCID: PMC3257903. 5: Vieira ML, Atzingen MV, Oliveira TR, Oliveira R, Andrade DM, Vasconcellos SA, Nascimento AL. In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PLoS One. 2010 Jun 22;5(6):e11259. doi: 10.1371/journal.pone.0011259. PubMed PMID: 20582320; PubMed Central PMCID: PMC2889836. 6: Sikora AG, Gelbard A, Davies MA, Sano D, Ekmekcioglu S, Kwon J, Hailemichael Y, Jayaraman P, Myers JN, Grimm EA, Overwijk WW. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res. 2010 Mar 15;16(6):1834-44. doi: 10.1158/1078-0432.CCR-09-3123. Epub 2010 Mar 9. PubMed PMID: 20215556; PubMed Central PMCID: PMC2858983. 7: Alizadeh H, Neelam S, Niederkorn JY. Role of activated macrophages in Acanthamoeba keratitis. J Parasitol. 2007 Oct;93(5):1114-20. doi: 10.1645/GE-1083R.1. PubMed PMID: 18163346. 8: Coon S, Shao G, Wisel S, Vulaupalli R, Sundaram U. Mechanism of regulation of rabbit intestinal villus cell brush border membrane Na/H exchange by nitric oxide. Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G475-81. PubMed PMID: 17290013. 9: Bodnárová M, Martásek P, Moroz LL. Calcium/calmodulin-dependent nitric oxide synthase activity in the CNS of Aplysia californica: biochemical characterization and link to cGMP pathways. J Inorg Biochem. 2005 Apr;99(4):922-8. PubMed PMID: 15811509. 10: Xu Z, Park SS, Mueller RA, Bagnell RC, Patterson C, Boysen PG. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res. 2005 Mar 1;65(4):803-12. PubMed PMID: 15721860. 11: Schaefer L, Beck KF, Raslik I, Walpen S, Mihalik D, Micegova M, Macakova K, Schonherr E, Seidler DG, Varga G, Schaefer RM, Kresse H, Pfeilschifter J. Biglycan, a nitric oxide-regulated gene, affects adhesion, growth, and survival of mesangial cells. J Biol Chem. 2003 Jul 11;278(28):26227-37. Epub 2003 Apr 27. PubMed PMID: 12719420. 12: Franco L, Doria D. Nitric oxide enhances prostaglandin production in ethanol-induced gastric mucosal injury in rats. Eur J Pharmacol. 1998 May 8;348(2-3):247-56. PubMed PMID: 9652340. 13: Ginsburg I, Kohen R. Synergistic effects among oxidants, membrane-damaging agents, fatty acids, proteinases, and xenobiotics: killing of epithelial cells and release of arachidonic acid. Inflammation. 1995 Feb;19(1):101-18. PubMed PMID: 7705882. 14: Christodoulides M, Boucher DW. The potency of tissue-type plasminogen activator (TPA) determined with chromogen and clot-lysis assays. Biologicals. 1990 Apr;18(2):103-11. PubMed PMID: 2115789. 15: Higazi AA, Mayer M. Effects of penicillins and 6-aminohexanoic acid on the kinetics of human plasmin. Biochem J. 1989 Jun 1;260(2):609-12. PubMed PMID: 2527494; PubMed Central PMCID: PMC1138714. 16: Simpson GM, Khajawall AM. Urinary acidifiers in phencyclidine detoxification. Hillside J Clin Psychiatry. 1983;5(2):161-8. PubMed PMID: 6423507.